EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H18N4O4S |
| Net Charge | 0 |
| Average Mass | 350.400 |
| Monoisotopic Mass | 350.10488 |
| SMILES | N[C@@H](CS/C(Cc1cnc2ccccc12)=N/O)C(=O)NCC(=O)O |
| InChI | InChI=1S/C15H18N4O4S/c16-11(15(22)18-7-14(20)21)8-24-13(19-23)5-9-6-17-12-4-2-1-3-10(9)12/h1-4,6,11,17,23H,5,7-8,16H2,(H,18,22)(H,20,21)/b19-13+/t11-/m0/s1 |
| InChIKey | PQEHILHGDWJAOT-YODGCNRUSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) has functional parent L-cysteinylglycine (CHEBI:4047) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) is a N-hydroxyimidothioate (CHEBI:136428) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) is a S-conjugate (CHEBI:64987) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) is a dipeptide (CHEBI:46761) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) is a indoles (CHEBI:24828) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) is tautomer of S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine zwitterion (CHEBI:136831) |
| Incoming Relation(s) |
| S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine zwitterion (CHEBI:136831) is tautomer of S-[(E)-N-hydroxy-2-(indol-3-yl)ethanimidoyl]-L-cysteinylglycine (CHEBI:137672) |
| IUPAC Name |
|---|
| S-[(1E)-N-hydroxy-2-(1H-indol-3-yl)ethanimidoyl]-L-cysteinylglycine |
| Synonyms | Source |
|---|---|
| indole-3-acetohydroximoyl-cysteinylglycine | MetaCyc |
| S-(indole-3-acetohydroximoyl)-L-cysteinylglycine | ChEBI |
| (E)-1-(glycyl-L-cystein-S-yl)-2-(1H-indol-3-yl)-acetohydroximate | MetaCyc |
| Manual Xrefs | Databases |
|---|---|
| CPD-12388 | MetaCyc |